Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Chemours (CC) Research & Development (2016 - 2025)

Historic Research & Development for Chemours (CC) over the last 12 years, with Q3 2025 value amounting to $26.0 million.

  • Chemours' Research & Development fell 1034.48% to $26.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $107.0 million, marking a year-over-year decrease of 183.49%. This contributed to the annual value of $109.0 million for FY2024, which is 92.59% up from last year.
  • Latest data reveals that Chemours reported Research & Development of $26.0 million as of Q3 2025, which was down 1034.48% from $28.0 million recorded in Q2 2025.
  • Chemours' Research & Development's 5-year high stood at $32.0 million during Q3 2022, with a 5-year trough of $24.0 million in Q1 2021.
  • Its 5-year average for Research & Development is $27.5 million, with a median of $27.0 million in 2021.
  • Its Research & Development has fluctuated over the past 5 years, first surged by 3500.0% in 2021, then tumbled by 1333.33% in 2023.
  • Quarter analysis of 5 years shows Chemours' Research & Development stood at $29.0 million in 2021, then increased by 3.45% to $30.0 million in 2022, then dropped by 13.33% to $26.0 million in 2023, then changed by 0.0% to $26.0 million in 2024, then changed by 0.0% to $26.0 million in 2025.
  • Its last three reported values are $26.0 million in Q3 2025, $28.0 million for Q2 2025, and $27.0 million during Q1 2025.